ANI Pharmaceuticals, Inc. (ANIP) Stock

ANI Pharmaceuticals, Inc., a prominent biopharmaceutical firm, specializes in the development, manufacturing, and distribution of branded and generic prescription pharmaceuticals across the United States and Canada. Founded in 2001 and headquartered in Baudette, Minnesota, ANI Pharmaceuticals focuses on a diverse range of therapeutic areas including controlled substances, oncology treatments, hormones, steroids, injectables, and various other formulations.

The company's manufacturing capabilities encompass oral solid dose products, semi-solids, liquids, topicals, and potent formulations. ANI Pharmaceuticals also provides contract development and manufacturing services to other pharmaceutical companies, reinforcing its role as a trusted partner in the industry.

ANI Pharmaceuticals distributes its comprehensive product portfolio through multiple channels including retail pharmacy chains, wholesalers, distributors, mail-order pharmacies, and group purchasing organizations. This extensive network ensures widespread availability of its medications to healthcare providers and patients alike.

Driven by a commitment to innovation and quality, ANI Pharmaceuticals continues to expand its market presence and therapeutic offerings. With a strategic focus on meeting the evolving needs of healthcare providers and enhancing patient care, the company remains dedicated to advancing pharmaceutical solutions that improve health outcomes across North America.